The cytokine interleukin-2 (IL-2) is critical for the functions of regulatory T cells (T regs ). The contribution of polymorphisms in the gene encoding the IL-2 receptor  subunit (IL2RA), which are associated with type 1 diabetes, is difficult to determine because autoimmunity depends on variations in multiple genes, where the contribution of any one gene product is small. We investigated the mechanisms whereby a modest reduction in IL-2R signaling selectively in T lymphocytes influenced the development of diabetes in the NOD mouse model. The sensitivity of IL-2R signaling was reduced by about two-to threefold in T regs from mice that coexpressed wild-type IL-2R and a mutant subunit (IL-2R
INTRODUCTION

CD4
+ Foxp3 + regulatory T cells (T regs ) maintain peripheral tolerance by suppressing autoreactive T cells that escape negative selection in the thymus. Interleukin-2 (IL-2), through its interaction with the high-affinity IL-2 receptor (IL-2R), which consists of IL-2R (CD25), IL-2R (CD122), and c (CD132), controls multiple critical activities in T regs (1) (2) (3) (4) . IL-2R signaling is essential for thymic T reg development, promoting the maturation of CD4 + CD25 lo Foxp3 lo immature cells into functional T regs (5) (6) (7) (8) (9) . IL-2 also contributes to T reg peripheral homeostasis (10) , in part by providing survival signals to central or resting CD62L hi T regs (11) and by supporting the development of terminally differentiated, short-lived Klrg1 + T regs (12) . T reg identity and suppressive function are enforced by IL-2 (13) through direct regulation of the expression of Foxp3. This property also influences the development of conventional T cells into peripherally induced T regs (14) (15) (16) . Because Foxp3 represses the expression of IL2, T regs constitutively express the high-affinity trimeric IL-2R to respond to IL-2 produced by effector T (Teff) cells and, in some cases, dendritic cells (17, 18) .
Multiple single-nucleotide polymorphisms (SNPs) in IL2, IL2RA, and IL2RB are associated with an increased risk for developing several human autoimmune diseases (19) . On their own, these IL-2-related SNPs, some of which are common in the population, represent a small risk for autoimmunity and most likely act in concert with SNPs in other genes as well as environmental factors to trigger autoimmunity. This complexity has made it difficult to determine how an individual SNP promotes autoimmunity. With respect to type 1 diabetes (T1D), individuals with susceptible SNPs in IL2RA (20) have a reduced abundance of CD25 on T reg and T memory cells, which leads to reduced IL-2R signaling (21) . Some data have also associated reduced IL-2R signaling in T regs with decreased fitness and suppressive function (22, 23) . Nevertheless, we still poorly understand how a subtle reduction in IL-2R signaling represents a risk for autoimmunity, including T1D.
The nonobese diabetic (NOD) mouse has been widely used as a model for T1D, where Il2 is a genetic risk for development of diabetes. The importance of the insulin-dependent diabetes risk locus 3 (Idd3), which contains Il2, for diabetes is illustrated by the substantial reduction in diabetes occurrence in NOD congenic mice in which the Idd3 interval is derived from C57BL/6 mice (24) . NOD Idd3 results in a twofold reduction in IL-2 production by CD4 + T cells (25) . Moreover, Il2 mRNA was selectively reduced in infiltrating cells in pancreatic islets of NOD mice when compared to that in peripheral immune tissues (26) . Reduced IL-2 production is associated with a pancreas-specific decrease in the T reg to Teff cell ratio, which might reflect impaired T reg homeostasis. Pancreatic T regs in NOD mice have reduced amounts of CD25 and Bcl-2 but increased Ki67 abundance, the latter of which may reflect a compensatory proliferative response toward autoreactive T cells (26, 27) . These studies concluded that the Il2-related genetic risk for diabetes in NOD mice is primarily due to a pancreas-specific impairment of T reg homeostasis that reduced the ability of these cells to suppress autoreactive T cells. However, these findings indirectly support these conclusions, and the effect on IL-2R signaling as a risk for diabetes remains poorly understood. An additional complication in clearly defining the Il2-related risk for diabetes in NOD mice is that the Idd3 locus also contains Il21, which is closely linked to Il2. This polymorphism in Il21 results in increased secretion of IL-21, a proinflammatory cytokine, and this increase in IL-21 abundance is linked to diabetes susceptibility in NOD mice (28) .
As discussed earlier, the direct contribution of the Il2-related risk for diabetes in NOD mice remains poorly understood. In addition, the reduced IL-2 production associated with the Idd3 locus does not directly test the consequences of altered IL-2R signaling, which is a risk for T1D and several other autoimmune diseases. To directly target IL-2R signaling, one must affect the activity of IL-2R, because this subunit is responsible for the distinct signaling attributed to IL-2. Simply knocking out Il2rb in the germ line or selectively in T regs leads to the production of immature, nonfunctional T regs , which results in rapid lethal systemic autoimmunity (29) (30) (31) ; this approach is not suitable to assess how subtle changes in IL-2R signaling might promote autoimmunity. For these reasons, we developed a model in which IL-2R signaling was selectively reduced in all T cells of NOD mice. We reasoned that IL-2R-dependent processes in T cells relevant to diabetes development in NOD mice would be intensified and thus distinguished from other genetic risks in this model. Diabetes was accelerated in male and female NOD mice in which IL-2R signaling was modestly and selectively reduced in T cells. Furthermore, this autoimmunity was directly related to substantial changes in T regs that included, but were not limited to, altered homeostasis and function, whereas more modest alterations were noted in the Teff compartment.
RESULTS
Expression of the IL-2R
Y3 transgene in NOD mice reduces IL-2R signaling We previously expressed a mutant IL-2R, designated IL-2R
Y3
, in mice such that three critical cytoplasmic tyrosine residues, Tyr 341 , Tyr
395
, and Tyr
498
, were mutated to phenylalanines (Y341F, Y395F, and Y498F) (32) . These mutations interfere with the association of the adaptor Shc and transcriptional regulator signal transducer and activator of transcription 5 (STAT5) to the cytoplasmic tail of IL-2R and thus substantially reduce IL-2R signaling. IL-2R Y3 was targeted for exclusive expression by T lymphocytes using the Cd2 minigene. When crossed onto the IL-2R −/− genetic background of C57BL/6 mice, the reduced IL-2R signaling associated with IL-2R Y3 outwardly supported normal T reg development, homeostasis, and function, whereas Teff and T memory compartments were much more obviously impaired (32 Y3 was detected on essentially all T lymphocytes (Fig. 1A) , as indicated by the increased mean fluorescence intensity (MFI) on T reg and CD8  + T cells, which also had endogenous  WT IL-2R, and by essentially all conventional CD4  + T cells, which  were mostly IL-2R neg in normal NOD mice. In contrast, the MFI of CD25 was reduced by 20 to 30% for T regs in NOD-Y3 mice for all examined tissues (Fig. 1B) . Because IL-2 increases the abundance of CD25 on the cell surface (33) , this result suggests that IL-2R signaling is reduced in T regs from NOD-Y3 mice.
Dose-response studies that assessed the tyrosine phosphorylation of STAT5 (pSTAT5) showed that T regs expressing IL-2R
Y3 had a reduced response to IL-2 (Fig. 1C) Y3 were 2.6-fold less responsive to IL-2 than were WT T regs (Fig. 1C) . In addition, the response by T regs to IL-2 was impaired in NOD-Y3 mice, as demonstrated by the decreased percentage of NOD-Y3 cells that were pSTAT5 + (Fig. 1D ). The reduced activation of STAT5 could be attributed to IL-2, because treatment of the mice with anti-IL-2 antibody for 24 hours substantially reduced the percentage of pSTAT5 + cells (Fig. 1D ). Minimal IL-2-dependent STAT5 phosphorylation was stimulated in conventional CD4 + and CD8 + T cells from NOD and NOD-Y3 mice when assessed directly ex vivo or after in vitro challenge with IL-2, which was due to the lack of the high-affinity IL-2R on these cells ( fig. S1, A (Fig. 1E ). This EC 50 shift was similar to that noted for IL-2 on T regs between NOD-Y3 and WT NOD mice (Fig. 1C) + T cells. This is an unavoidable potential off-target consequence of directly interfering with IL-2R signaling.
IL-2R
Y3 accelerates the onset and increases the penetrance of diabetes in NOD-Y3 mice IL-2R Y3 acted in a dominant-negative manner to reduce IL-2R signaling by two-to threefold in NOD-Y3 mice. Therefore, we assessed the consequences of this modest reduction in IL-2R signaling by comparing diabetes onset in male and female NOD and NOD-Y3 mice ( Fig. 2A ) and NOD and NOD-Y3 BDC2.5 T cell receptor (TCR) transgenic mice (Fig. 2B) , whose CD4 + T cells express a TCR specific for the chromogranin A autoantigen. In male mice, the average time to diabetes onset was 23 weeks for NOD-Y3 mice but was greater than 40 weeks for WT NOD mice. In female mice, the average diabetes onset was 18 weeks for NOD-Y3 mice but was 27 weeks for WT NOD mice ( Fig. 2A) . Similarly, average diabetes onset was accelerated in both male and female NOD-Y3 BDC2.5 mice (Fig. 2B) . Because of the unexpected break in tolerance in male mice, most of our further studies focused on male NOD and NOD-Y3 mice.
In polyclonal mice, serum insulin autoantibody titers were also greater in male and female NOD-Y3 mice than in NOD mice when measured at 12 weeks of age (Fig. 2C) . The overall cell numbers recovered cytometry analysis of pSTAT5 abundance in T regs directly after isolation from the indicated mice (n = 5). In some cases, the NOD mice were treated with Hanks' balanced salt solution (HBSS) (n = 4) or anti-IL-2 (n = 6) for 24 hours before the cells were isolated and analyzed for pSTAT5. The resulting data were analyzed by Mann-Whitney test. (E) Flow cytometry analysis of pSTAT5 abundance in the indicated T cell populations stimulated in vitro with the indicated concentrations of IL-15 for 15 min. Dose-response curves (left) were subjected to nonlinear regression analysis to determine the EC 50 values (right), which were analyzed by the Mann-Whitney test (n = 6). **P < 0.01, ***P < 0.001, ****P < 0.0001.
from the pancreatic lymph node (PLN) and the pancreas were slightly, but not significantly, increased in male NOD-Y3 mice compared to those in male NOD mice (Fig. 2D ). Male NOD and NOD-Y3 mice also had a similar percentage of islets showing lymphocytic infiltration; however, NOD-Y3 mice had more late-stage infiltration compared to that of the WT controls (Fig. 2E ). These data suggest that lymphoid cells present in the pancreas were somewhat more effective in attacking islet tissues in the NOD-Y3 pancreas and likely contributed to the acceleration of diabetes onset.
IL-2R Y3 alters T regs and antigen-experienced T cells in NOD mice
Although the overall cellularity in male NOD-Y3 mice was relatively normal, the T lymphocyte composition was distinctive in lymphoid tissues and the pancreas. There were less T regs in the spleen, PLN, and pancreas of NOD-Y3 mice compared to those of NOD mice (Fig. 3A) . These T regs exhibited a slight but statistically significant reduction in Foxp3 abundance together with a reduced amount of CD25 (Fig. 1B) . Conventional CD4 + T cells were slightly increased in number in the spleen and PLN, whereas antigen-experienced CD4 + Foxp3 − CD44
hi T cells were increased in number in the PLN and pancreas (Fig. 3B) . In contrast, a reduced fraction of CD8 + T cells was noted for these tissues, whereas the proportion of antigen-experienced CD8 + CD44 hi T cells remained largely unaltered (Fig. 3C ). Most of these changes were also noted for female NOD-Y3 mice ( fig. S2 ). Two exceptions included a less marked effect on T reg and CD4 + Foxp3 − CD44 hi percentages in the pancreas of female NOD and NOD-Y3 mice. This result is most likely because inflammation leading to diabetes is normally more severe in female NOD mice than in male NOD mice, which might have obscured the effects of IL-2R Y3 primarily affects T cells and that these changes are sufficient to accelerate the onset of diabetes.
IL-2R Y3 increases the numbers of CD4 + Teff cells but decreases the numbers of CD8 + Teff cells in NOD-Y3 mice To further evaluate the effects of IL-2R
Y3 on the conventional T cell compartment, we assessed cytokine production after stimulation of the T cells with phorbol 12-myristate 13-acetate (PMA) and ionomycin. Increased numbers of tumor necrosis factor- (TNF-)-and IL-2-producing CD4 + CD44 hi T cells were present in the PLNs of NOD-Y3 mice (Fig. 3D ). These data associate the increased activity of CD4 + CD8 + CD44 hi T cells was noted for NOD-Y3 mice, which was most obvious in the spleen (Fig. 3E) . Thus, IL-2R Y3 did not substantially alter the frequency of T helper 1 cells (T H 1) and T H 17 cells, which have been suggested to drive diabetes in NOD mice (35) .
Reduced IL-2R signaling accounts for the altered numbers of CD4 + but not of CD8 + T cells in NOD-Y3 mice The expression of IL-2R
Y3 resulted in a two-to threefold reduction in IL-15R signaling CD8 + T cells. IL-15 is important for the persistence of CD8 + T memory cells (36, 37) . Thus, the lower proportion ( Fig. 3C ) and functional activity (Fig. 3E ) of CD8 + T cells in NOD-Y3 mice might reflect impaired IL-15 signaling. Therefore, we also examined the effect of acute treatment with anti-IL-2 on WT NOD mice for (E) Pancreatic islet infiltration scoring by hematoxylin and eosin staining of pancreas sections from male mice at 7 to 12 weeks of age (>200 islets were evaluated). *P < 0.05, **P < 0.01. (Fig. 3, F and G) . In contrast, anti-IL-2 had minimal effect on the overall proportion of CD8 + T cells and distribution of CD8 + antigen-experienced cells in NOD mice (Fig. 3G ). Thus, these data are consistent with the notion that IL-2R
Y3 alters the CD4 + T reg and CD4 + Foxp3 − antigen-experienced T cell compartments by reducing IL-2R signaling, whereas the reduction in the number of CD8 + T cells is likely a result of reduced IL-15R signaling.
T reg subsets from IL-2R Y3 mice have properties consistent with altered homeostasis T regs have been divided into subsets whereby increased cell surface expression of CD62L or CCR7 marks resting or central T regs (cT regs ), whereas reduced expression of these molecules marks activated or effector T regs (eT regs ) (11) . Gene expression analysis indicates that eT regs are heterogeneous; eT regs that express CD69, CD103, or Klrg1 are more highly activated than their negative counterparts. In particular, these more activated eT regs have increased amounts of T reg functional molecules and chemokine receptors that promote cell trafficking into nonlymphoid tissues, among other changes (38, 39) .
Because T regs were consistently decreased in number in NOD-Y3 mice, including those that expressed the BDC2.5 TCR, we further focused on how IL-2R Y3 might affect these cells. We assessed these T reg subsets on the basis of their cell surface expression of CD62L and CD69 (Fig. 4A ) and their expression of Ki67 (Fig. 4B ) and Bcl-2 (Fig. 4C ). This analysis revealed that NOD-Y3 mice had a reduced proportion of CD62L hi CD69 − cT regs compared to that of NOD mice (Fig. 4D) . Accordingly, the spleen and pancreas contained an increased proportion of less activated CD69 − eT regs (Fig. 4E) , whereas the PLN contained more CD69 + eT regs (Fig. 4F) . This altered distribution of T reg subsets in NOD-Y3 mice is accounted for in part by the altered homeostasis of these cells, as reflected by the increased abundance of Ki67 and the decreased abundance of Bcl-2. This phenotype was most apparent with cT regs (Fig. 4D) , which depend on IL-2 for their survival (11) . However, these changes were also noted for CD69 − (Fig. 4E ) and CD69 + (Fig. 4F ) eT regs . The increased abundance of Ki67 likely reflects the increased proliferation of T regs to compensate for their impaired survival.
Transcriptional changes imposed by IL-2R Y3 for T regs from the pancreas were determined using the NanoString platform, which measures the expression of 547 immune-related genes. We found that 236 mRNAs were expressed by these T regs , and 32 mRNAs were significantly differentially expressed (P ≤ 0.05; table S1, P < 0.05). Consistent with our flow cytometry analysis, T regs from NOD-Y3 mice expressed less Il2ra (CD25) and Sell (CD62L) mRNAs than did T regs from NOD mice (Fig. 4G) . A group of differentially expressed genes related to eT regs exhibited decreased expression in IL-2R Y3 T regs , including Irf4, Prdm1, Il10, and Cd247 (CD3). Interferon regulatory factor 4 (IRF4) and TCR signaling are essential for eT reg development (40, 41) , whereas Blimp-1 promotes IL-10 production by eT regs (40) . Although Il10 expression was decreased, gene expression of other T reg functional molecules, such as Ctla4, Ccr6, Entpd1, Nt5e, and Tgfb1, were not differentially expressed between NOD and NOD-Y3 mice. Thus, these data suggest that, in addition to leading to altered T reg homeostasis, IL-2R
Y3 also leads to a pancreatic T reg signature of reduced functional activity due in part to the impaired development of the more highly activated, IL-10-producing eT regs .
IL-2R
Y3 intrinsically alters the activity of CD4 − T cells minimally increased in number in the spleen but substantially increased in the pancreas because of increased proliferation as determined by measuring Ki67 abundance (Fig. 5C ). Furthermore, NOD-Y3 BDC2.5 T regs were found at a much lower proportion than NOD BDC2.5 T regs , consistent with an inability to suppress the autoreactive BDC2.5 T cells (Fig. 5D ). These data suggest that IL-2R Y3 directly dysregulates T reg function.
Y3 impairs the homeostasis of T reg subsets To assess the possibility that altered T reg homeostasis also contributed to the acceleration of diabetes in NOD-Y3 mice, mixed bone marrow chimeric mice were prepared such that irradiated NOD.SCID recipients received a 1:1 mixture of T cell-depleted bone marrow from NOD and NOD-Y3 mice (Fig. 6A) . Eight weeks after transplantation, the distribution of donor T cells was assessed for the spleen, PLN, and pancreas (Fig. 6B) . T regs of IL-2R Y3 origin were substantially underrepresented in these recipients, whereas equivalent proportions of CD4 + Foxp3 − and CD8 + T cells of WT and IL-2R Y3 origin were found in these tissues (Fig. 6C) . In addition, IL-2R Y3 T regs had decreased amounts of CD25 and Foxp3, consistent with reduced IL-2R signaling, and had decreased Ki67 abundance, consistent with impaired proliferation (Fig. 6D) .
Although cT regs were reduced in number in NOD-Y3 mice compared to those in NOD mice (Fig. 4D) , the proportions of cT regs and eT regs did not substantially vary between T regs of NOD and NOD-Y3 origin in the bone marrow chimeras (Fig. 6E) . However, the number of NOD-Y3 eT regs that expressed CD103, inducible T cell costimulator (ICOS), and Klrg1 was statistically significantly reduced, consistent with the impaired development of highly activated and terminally differentiated T regs . If cell numbers rather than percentages are considered, then the numbers of IL-2R Y3 cT regs and most eT reg subsets were markedly reduced (Fig. 6F) . These data indicate that IL-2R Y3 cT regs did not effectively compete with WT NOD cT regs , consistent with the impaired homeostasis of this T reg subset, and suggest that IL-2R Y3 T regs cannot properly develop into highly activated subsets.
Y3 impairs the development of eT reg subsets To directly assess the development of eT regs from cT regs , CD62L hi cT regs were isolated from NOD and NOD-Y3 mice and transferred at a 1:1 ratio into NOD-Y3 IL-2R −/− recipient mice (Fig. 7A) . We have previously used this type of recipients, but on the C57BL/6 genetic background, to Mann-Whitney test. (G) The abundances of the indicated mRNAs in pancreatic T regs from male NOD and NOD-Y3 mice were assessed with the NanoString platform. Data were analyzed by two-tailed unpaired t test with the nSolver analysis software package from NanoString (n = 3). WT, wild-type. *P < 0.05, **P < 0.01, ****P < 0.0001.
study T reg subset development (38). T regs from C57BL/6-Y3 IL-2R
−/− mice have a more substantial block in IL-2R signaling than T regs from C57BL/6-Y3 IL-2R +/+ mice (32), but they are not lymphopenic. These properties were also found for NOD-Y3 IL-2R +/+ and NOD-Y3 IL-2R −/− mice (Fig. 1C) . When C57BL/6-Y3 IL-2R −/− mice were used as recipients, reduced IL-2R signaling associated with recipientderived T regs was favorable for engraftment of relatively small numbers of donor cT regs . This environment makes it feasible to study the development of T reg subpopulations in vivo without any conditioning regimen to make space for donor T regs .
We purified cT regs based on CD4 + T cells that coexpressed CD25 and CD62L (Fig. 7B) . Donor WT cells were >93% Foxp3 + . Engrafted WT donor T regs were identified solely on the basis of their expression of CD45.2, whereas donor IL-2R Y3 T regs were identified on the basis of their expression of CD45.1 and red fluorescent protein (RFP; Fig. 7C (Fig. 7D) . T regs of NOD-Y3 origin expressed less CD25 and CD62L, the latter indicative of a reduced proportion of cT regs (Fig. 7D) . These data further demonstrate the impaired homeostasis of cT regs with reduced IL-2R signaling associated with IL-2R
Y3
. Furthermore, the development of eT regs was also abnormal. Compared to WT T regs , IL-2R Y3 T regs had reduced amounts of ICOS, CD103, and Klrg1 (Fig. 7D) . These data indicate that IL-2R Y3 T regs are impaired in their ability to generate highly activated eT reg subsets. Together, these data suggest that reducing IL-2R signaling in T regs leads to compromised homeostasis of cT regs and the altered development of eT regs .
DISCUSSION
Past studies provided some initial information consistent with the notion that variation in the genes encoding IL-2 or the IL-2R in mice and humans reduces the activity of T regs (21, 24, 26) , but little is understood regarding how this genetic variation represents a risk for autoimmunity. Here, we directly reduced IL-2R signaling in T cells and showed that modestly, but chronically, reducing IL-2 responsiveness by about 2.6-fold accelerated diabetes in male and female NOD mice. Our findings demonstrate that accelerated diabetes occurs because of a multiplicity of effects on T regs that affect their homeostasis and function. Altered T reg homeostasis by IL-2R Y3 was evident because T regs from NOD-Y3 mice were broadly characterized by having increased amounts of Ki67 but decreased Bcl-2 abundance. This phenotype is consistent with T regs that undergo increased proliferation to counterbalance enhanced cell death. Reduced IL-2R signaling affected T reg homeostasis in two distinct ways. First, cT regs (as defined by high expression of CD62L) were found at a reduced proportion under several different experimental conditions when they expressed IL-2R
Y3
, and this effect may reflect impaired survival because IL-2 promotes the survival of this T reg subset (11) . Second, the development of more highly activated eT regs [identified on the basis of the expression of CD103 and Klrg1 by CD62L lo T regs (38) ] was less efficient for T regs with reduced IL-2R signaling. This was most obviously seen in experiments with mixed bone marrow chimeras and the direct development of eT regs from purified adoptively transferred cT regs . The expression of Klrg1 by eT regs represents a terminally differentiated state of activation and occurs only after more than eight or nine cell divisions as cT regs develop into eT regs (12) . The observation that reduced IL-2R signaling led to fewer Klrg1 + eT regs is likely explained by eT regs that die before reaching this state of activation.
In other systems, blockade of IL-2R signaling destabilizes T regs so that they become IFN- + and IL-17 + Teff cells; this process is most evident for peripherally derived T regs (42, 43) . Our experimental design did not enable us to directly assess this process, and some of the decrease in T reg number that we noted might be due to their development into Teff cells. However, several observations suggest that this mechanism does not fully account for the accelerated onset of diabetes in NOD-Y3 mice. First, we did not detect increases in the numbers of IFN--and IL-17-producing CD4 + T cells in NOD-Y3 mice. If T reg conversion to T H 1 and T H 17 Teff cells was a main mechanism, these cells should have increased in number, particularly in the pancreas. Second, TCR repertoire studies indicate that most T regs in the peripheral immune tissues are thymus-derived cells (44) and have a stable phenotype (45) . Thus, the poor persistence of adoptively transferred IL-2R Y3 T regs is unlikely to be due to the few peripherally derived T regs that may be part of the donor inoculum.
This study also begins to provide a molecular underpinning for the dysregulation associated with IL-2R Y3 T regs . IRF4 is required for the cT reg -to-eT reg developmental step (40) . Blimp-1 is selectively expressed by eT regs and contributes to the production of IL-10 (40). Broad immune mRNA profiling by NanoString analysis showed that all of these mRNAs were less abundant in pancreatic T regs of NOD-Y3 mice than in those of WT mice. These data are consistent with reduced IL-2R signaling interfering with the development of eT regs through an IRF4-Blimp-1-IL-10 axis. Activated STAT5 directly regulates the expression of Il2ra, Foxp3, Irf4, and Prdm1 (46) (47) (48) . In addition, Il2ra, Irf4, and Prdm1 are direct targets of Foxp3 (49) . Thus, subtly and chronically reducing both IL-2R signaling and the abundance of Foxp3 by IL-2R Y3 might cooperatively act to impair eT reg development. TCR signaling also importantly contributes to the development of eT regs (41) . Thus, the reduced abundance of CD3 in pancreatic IL-2R Y3 T regs raises the possibility that IL-2R Y3 might also influence eT reg development by reducing TCR signaling, but this requires further investigation.
We showed that IL-2R Y3 directly reduced functional activity by demonstrating the inability of T regs from NOD-Y3 BDC2.5 mice to suppress autoreactive BDC2.5 T cells and diabetes development in a NOD.SCID transfer model. The effect of IL-2R Y3 on T regs is predicted to reduce T reg function in several important ways. The impaired homeostasis of cT regs and eT regs likely diminishes the capacity of T regs that reside in lymph nodes and tissue sites, respectively, to properly balance their numbers with autoreactive T cells. Furthermore, Klrg1 + and CD103
+ eT regs are characterized by having increased amounts of several T reg functional molecules and tissue-targeting chemokine receptors (38, 39) . Thus, IL-2-dependent alterations in eT reg development affect T reg function indirectly by reducing the proportions of T regs with enhanced suppressive function, as well as directly by decreasing the amount of IL-10.
Previous studies designed to ascertain the contribution of IL-2R signaling to diabetes in NOD mice have been indirect in that they assessed the potential effects of reduced IL-2 production, especially by pancreatic T cells, on T regs 'due to the Idd3 polymorphism (26) . These studies implied that NOD T reg homeostasis was impaired as reflected by their altered amounts of Ki67 and Bcl-2, which we confirmed. A complication of the past results is that Idd3 not only reduces IL-2 but also increases the production of the proinflammatory cytokine IL-21 (28) , which might also contribute to the development of diabetes. Thus, an advantage of IL-2R Y3 is that IL-2R signaling is directly targeted. The caveat with IL-2R Y3 is that IL-15R signaling is also reduced. This was detected in T regs and CD8 + T cells. However, the T reg compartment is largely normal in IL-15-deficient mice (6), and we showed that in situ pSTAT5 activation by T regs was inhibited by anti-IL-2, indicating that impaired IL-2R signaling largely accounted for the intrinsic effects of IL-2R Y3 on T regs . In contrast, the lower proportion of CD8 + T cells associated with NOD-Y3 mice was unaffected by anti-IL-2. These results, in conjunction with the known role of IL-15 in CD8 + T cell homeostasis (50, 51) , suggest that the decrease in the number of CD8 + T cells is accounted for by reduced IL-15R signaling. CD8 + T cells and increased IL-15 signaling have been implicated in promoting diabetes in NOD mice (52) . Thus, a reduction in these two parameters by IL-2R Y3 is not expected to be a contributing factor to the accelerated disease in NOD-Y3 mice.
Upon reducing IL-2R signaling in T cells, T regs were intrinsically affected in a manner that would reduce peripheral tolerance, as discussed earlier. Reduced IL-2R signaling is also expected to reduce T H 1 and T H 2 responses (53-56), which should not accelerate diabetes. However, decreased IL-2R signaling could intrinsically increase the concentration of IL-2, T H 17s, and T follicular helper (Tfh) cells (57, 58) , whereas increased IL-17 has been linked to diabetes in NOD mice (59) . We observed an increase in antigen-experienced CD4 + T cells in NOD-Y3 mice, which included increased numbers of IL-2-producing, but not IL-17-producing, T cells in the PLN. Increased anti-insulin from the indicated tissues (n = 5 to 6) and their expression of CD62L (n = 5 to 6), CD25 (n = 5 to 6), CD103 (n = 3 to 4), Klrg1 (n = 4 to 6), and ICOS (n = 5 to 6) from the indicated tissues. Data were analyzed by Wilcoxon signed-rank test for MFIs, whereas the Mann-Whitney test was used for the remaining samples. *P < 0.05, **P < 0.01.
autoantibodies were also observed, which may reflect an increase in the number of Tfh cells due to reduced STAT5 and Blimp-1-mediated repression (57) . However, transfer studies of CD4 + Foxp3 − T cells into NOD.SCID mice did not provide clear evidence that IL-2R Y3 enhanced the activity of autoreactive T cells. A more difficult question to resolve is whether accelerated diabetes in NOD-Y3 mice is due to the reduced intrinsic IL-2R signaling by autoreactive T cells that enhances their activity or is simply the result of reduced T reg activity.
Although male NOD mice are relatively resistant to diabetes, a particularly marked result was that NOD-Y3 males developed diabetes at a similar rate to that of NOD females. Sex-biased development of T1D in NOD mice has been attributed to differences in microbiota and sex hormones (60) (61) (62) . Differences in sex hormones have been suggested to influence the type of microbiota in male and female NOD mice (62) , raising the possibility that these two factors are interrelated. Although our study did not address the factors responsible for the lack of sex bias in NOD-Y3 mice, we speculate that altering the number of eT regs (which dominate the gut mucosa) through reduced IL-2R signaling distinctively shapes immune homeostasis in the gut mucosa to influence the microbiota in a way that promotes diabetes in both male and female mice. Alternatively, decreased T reg function as a result of reduced IL-2R signaling in NOD-Y3 mice may be sufficient to counteract the protective effects in male NOD mice that are attributed to microbiota and sex hormones. Experimentation is required to assess these points.
The IL-2-IL-2R axis has been implicated as a risk factor not only for T1D but also for other autoimmune diseases, including multiple sclerosis, celiac disease, and rheumatoid arthritis. IL-2R
Y3 reduced IL-2R signaling in all T cells, and this situation is predicted to mimic genetic variation due to SNPs within the noncoding region of IL2RA that may alter gene expression. Thus, the effects that we noted in NOD-Y3 mice might also be detected in humans that carry some IL2RA risk alleles. In addition, low-dose IL-2 represents a promising strategy to boost T regs in patients with autoimmunity (63) . Our study raises the possibility that along with evaluating the capacity of low-dose IL-2 to increase the total number of T regs , one may also wish to assess how this treatment affects particular subsets of T regs to maximize therapeutic benefits. −/− mice (32) to NOD/ShiLtJ mice for 12 generations. All Idd loci were confirmed to be of NOD origin. NOD/Foxp3-RFP reporter (FIR) mice were previously described (64) and crossed to NOD BDC2.5 and NOD-Y3 IL-2R +/+ mice to yield NOD-Y3-FIR, NOD BDC2.5-FIR, and NOD-Y3 BDC2.5-FIR mice. All mice were housed in a specific pathogen-free animal facility at the University of Miami. The Institutional Animal Care and Use Committee at the University of Miami reviewed and approved all animal studies conducted in this study.
MATERIALS AND METHODS
Mice
Assessment of diabetes, insulin autoantibodies, and islet infiltration scoring
Diabetes was determined by following urine glucose two to three times per week using Diastix strips (Bayer) . After two positive urine tests (>250 mg/dl), blood glucose was assessed using OneTouch Ultra strips. Mice were considered diabetic when blood glucose readings were >250 mg/dl. Serum was analyzed for insulin autoantibodies by radioimmunoassay as previously described (65) . To assess islet inflammation, the pancreas was fixed in 10% neutral buffered formalin, embedded in paraffin, cut into 5-m sections, and stained with hematoxylin and eosin. Lymphocytic infiltration was scored for each islet and assessed blindly by light microscopy. Insulitis scoring was conducted per the following criteria: 0, no insulitis (free of infiltration); 1, peri/polar insulitis (infiltration confined to the periphery of islets); 2, mild insulitis (<50% of the islet area infiltrated); 3, severe insulitis (≥50% of the islet area infiltrated); and 4, massive insulitis (≥90% of the islet area infiltrated) (66) .
Fluorescence-activated cell sorting analysis
Cell staining for fluorescence-activated cell sorter (FACS) analysis was performed as previously described (67) . Monoclonal antibodies (mAbs) specific for the following targets were used for flow cytometry: CD25 (PC61), pSTAT5 (pY641), Ki67 (B56), and CD11c (HL3) were purchased from BD Biosciences; and Foxp3 (FJK-16s), CD62L (MEL-14), IL-2 (JES6-5H4), CD103 (2E7), Klrg1 (2F1), ICOS (15F9), and streptavidin were purchased from eBioscience. Antibodies against CD122 (Tm-b1), CD4 (RM4-5), CD8 (53-6.7), IFN- (XMG1.2), TNF- (MPG-XT22), IL-17 (TC11-18H10.1), CD69 (H1.2F3), Bcl-2 (BCL/10C4), CD45.1 (A20), CD45.2 (104), CD19 (GD5), CD49b (DX5), Ly6G (1A8), CD11b (M1/70), and streptavidin were purchased from BioLegend. Antibodies against CD4 (GK1.5) and CD44 (PGP-1) were purified and conjugated in-house. Intracellular staining for Foxp3 (eBioscience) was performed as recommended by the manufacturer. For intracellular staining of cytokines, the BD Cytofix/Cytoperm kit was used according to the manufacturer's protocol. Samples were analyzed on a BD LSRFortessa-HTS or a BD LSR II flow cytometer. Typically, 200,000 total events were collected per sample. Flow cytometry data were analyzed with BD FACSDiva software (version 8.0.1).
Cell isolation and sorting
To isolate lymphoid cells from the mouse pancreas, pancreases were minced into about 2-mm 2 pieces in Hanks' balanced salt solution (HBSS) containing 50% fetal calf serum (FCS) and incubated at 37°C for 3 hours in a 7% CO 2 incubator. The total pancreas pieces were then passed through a 70-m nylon strainer (Falcon). The resulting singlecell suspension was centrifuged at 480g for 5 min, pelleted, and then washed once with HBSS. To prepare T cell-depleted bone marrow cells, mAbs against CD4 (0.2 ml of culture supernatant; RL1724), CD8 (0.2 ml of culture supernatant; HO22), Thy-1.2 (10 g of purified antibody; 30-H12, Sigma-Aldrich), deoxyribonuclease (10 g; SigmaAldrich), and rabbit complement (0.12 ml; Cedarlane Laboratories) were added to 1 ml of bone marrow cells (25 × 10 6 /ml in RPMI 1640 containing 5% FCS). This mixture was incubated on ice for 15 min and then incubated at 37°C for 30 min. After this time, the cells were washed once in RPMI 1640. In most experiments, CD4 + T regs and T conventional cells from the spleen or pancreas were surface-stained and sorted on the basis of the presence or absence, respectively, of the Foxp3-RFP reporter with FACSAria II or Beckman Coulter MoFlo Astrios EQ cell sorters. Cell purity was usually greater than 95%. For the adoptive transfer of T regs into NOD-Y3 IL-2R −/− mice, where some donor mice were not on the Foxp3-RFP reporter background, T regs were sorted on the basis of CD4 + CD62L hi CD25 hi expression. This population was greater than 93% Foxp3 + cells.
Functional and molecular analyses
To measure intracellular cytokines by flow cytometry, cells (1 × 10   6 to 2 × 10 6 ) were cultured in 24-well flat-bottom plates with RPMI 1640 complete medium (68) containing PMA (50 ng/ml), ionomycin (1 M), and brefeldin A (5 g; BioLegend) for 4 hours. To assess mRNA abundance, cell lysates from FACS-purified cells were prepared with RLT lysis buffer (Qiagen). These lysates (10,000 cell equivalents) were subjected to NanoString analysis using the nCounter Mouse Immunology Gene Expression Code set (NanoString). Expression data were analyzed by normalizing counts to housekeeping genes and positive and negative controls using nSolver version 2.5 (38) . Normalized counts were log 2 −transformed, and the data were analyzed by Student's two-tailed t test. IL-2-dependent (eBioscience) and IL-15-dependent (PeproTech) pSTAT5 activation was assessed by flow cytometry as previously described (7), either directly ex vivo or after stimulation in vitro with the appropriate cytokine for 15 min. The resulting doseresponse curve data were subjected to nonlinear regression analysis using GraphPad Prism software to determine the EC 50 .
In vivo studies
For adoptive transfer studies, the appropriate cell populations were transferred intravenously through the tail vein into NOD.SCID or NOD-Y3 IL-2R −/− recipient mice. Glucose concentrations were monitored in the NOD.SCID recipients for up to 24 days after transfer, as required. For bone marrow chimeras, 1 day before cell transfer, NOD. SCID recipients were subjected to 3.5 Gy of  irradiation. Donor T celldepleted bone marrow was mixed, as indicated in Results, and injected intravenously into the tail vein. Blood was collected to monitor donor cell reconstitution before the recipient mice were sacrificed 8 weeks after transfer.
Statistical analysis
All data are represented as means ± SEM. Statistical tests used are listed in the figure legends. Data were analyzed using Wilcoxon signed-rank tests for FACS expression based on the MFI, where the MFI of cells from WT NOD mice were normalized to 1. The log-rank test was used to assess diabetes instances, the Kruskal-Wallis test was used to assess multigroup comparisons, and the Mann-Whitney test was used to assess autoantibody titers and two group comparisons. Twotailed unpaired t tests were used to analyze pancreatic T reg NanoString data. Statistical comparisons were performed using GraphPad Prism (version 7.01). Statistical significance is indicated in the figure legends as follows: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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